Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial

INTRODUCTION: It is the common clinical practice to prescribe indefinite aspirin for patients with non-valvular atrial fibrillation (NVAF) post left atrial appendage occlusion (LAAO). However, aspirin as a primary prevention strategy for cardiovascular diseases has recently been challenged due to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mu, Wang, Qunshan, Sun, Jian, Zhang, Peng-Pai, Li, Wei, Mo, Bin-Feng, Chen, Tai-Zhong, Tang, Xiaoli, Li, Yi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970210/
https://www.ncbi.nlm.nih.gov/pubmed/33722871
http://dx.doi.org/10.1136/bmjopen-2020-044695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970210/
https://www.ncbi.nlm.nih.gov/pubmed/33722871
http://dx.doi.org/10.1136/bmjopen-2020-044695

Ejemplares similares